Dana Delaski, NP-C

NPI: 1467753772
Total Payments
$145,155
2024 Payments
$12,552
Companies
65
Transactions
679
Medicare Patients
986
Medicare Billing
$91,010

Payment Breakdown by Category

Other$84,118 (58.0%)
Travel$44,249 (30.5%)
Food & Beverage$14,903 (10.3%)
Consulting$1,707 (1.2%)
Education$178.99 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $84,118 61 58.0%
Travel and Lodging $44,249 106 30.5%
Food and Beverage $14,903 507 10.3%
Consulting Fee $1,707 3 1.2%
Education $178.99 2 0.1%

Top Paying Companies

Company Total Records Latest Year
Incyte Corporation $136,078 326 $0 (2024)
Vertex Pharmaceuticals Incorporated $931.76 1 $0 (2022)
Celgene Corporation $482.96 17 $0 (2024)
BeiGene USA, Inc. $474.75 12 $0 (2024)
GENZYME CORPORATION $474.38 25 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $361.18 16 $0 (2024)
AstraZeneca Pharmaceuticals LP $360.51 10 $0 (2024)
E.R. Squibb & Sons, L.L.C. $351.30 6 $0 (2022)
Genentech USA, Inc. $324.94 14 $0 (2024)
Pharmacosmos Therapeutics Inc. $297.56 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $12,552 154 Incyte Corporation ($10,071)
2023 $40,084 190 Incyte Corporation ($38,538)
2022 $53,254 163 Incyte Corporation ($50,675)
2021 $39,265 172 Incyte Corporation ($36,794)

All Payment Transactions

679 individual payment records from CMS Open Payments — Page 1 of 28

Date Company Product Nature Form Amount Type
12/31/2024 Janssen Biotech, Inc. TECVAYLI (Biological) Food and Beverage In-kind items and services $24.59 General
Category: Oncology
12/20/2024 BeiGene USA, Inc. TEVIMBRA (Drug) Food and Beverage In-kind items and services $16.55 General
Category: Oncology
12/18/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $9.93 General
Category: Hematology
12/17/2024 PharmaEssentia USA Corporation BESREMI (Drug) Food and Beverage In-kind items and services $25.16 General
Category: Oncology
12/16/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $26.00 General
Category: Rare Disease
12/13/2024 Incyte Corporation MONJUVI (Drug) Food and Beverage Cash or cash equivalent $18.91 General
Category: Oncology
12/10/2024 Legend Biotech USA Inc. Food and Beverage In-kind items and services $22.56 General
12/09/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $18.95 General
Category: Oncology
12/06/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $24.41 General
Category: Oncology
12/06/2024 Janssen Biotech, Inc. DARZALEX (Biological), TECVAYLI, TALVEY Food and Beverage In-kind items and services $13.86 General
Category: Oncology
12/02/2024 Boehringer Ingelheim Pharmaceuticals, Inc. GILOTRIF (Drug) Food and Beverage In-kind items and services $15.33 General
Category: ONCOLOGY
11/25/2024 Janssen Biotech, Inc. TECVAYLI (Biological) Food and Beverage In-kind items and services $20.63 General
Category: Oncology
11/22/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $26.63 General
Category: Oncology
11/19/2024 Immunocore Limited KIMMTRAK (Drug) Food and Beverage In-kind items and services $15.52 General
Category: Oncology
11/18/2024 Aveo Pharmaceuticals, Inc. FOTIVDA (Drug) Food and Beverage In-kind items and services $20.91 General
Category: Oncology
11/13/2024 Celgene Corporation Food and Beverage Cash or cash equivalent $24.29 General
11/12/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $26.91 General
Category: Acute Myeloid Leukemia
11/12/2024 ARRAY BIOPHARMA INC BRAFTOVI (Drug), MEKTOVI, TUKYSA Food and Beverage In-kind items and services $15.27 General
Category: ONCOLOGY
11/11/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $23.03 General
11/08/2024 PFIZER INC. ELREXFIO (Drug), ADCETRIS Food and Beverage In-kind items and services $18.36 General
Category: ONCOLOGY
11/07/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $13.33 General
Category: Oncology
10/28/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $24.60 General
Category: Oncology
10/23/2024 Incyte Corporation MONJUVI (Drug) Food and Beverage Cash or cash equivalent $22.52 General
Category: Oncology
10/17/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $19.69 General
Category: ONCOLOGY
10/16/2024 RECORDATI_RARE_DISEASES_INC. SYLVANT (Drug) Food and Beverage In-kind items and services $20.53 General
Category: ONCOLOGIC AGENT

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 209 352 $87,370 $19,331
2022 3 212 341 $82,793 $21,655
2021 4 276 434 $81,955 $24,724
2020 3 289 487 $106,385 $25,300
Total Patients
986
Total Services
1,614
Medicare Billing
$91,010
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 122 235 $58,045 $12,839 22.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 35 48 $17,664 $4,016 22.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 52 69 $11,661 $2,475 21.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 65 125 $39,336 $10,812 27.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 92 149 $33,278 $8,303 25.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 55 67 $10,179 $2,540 25.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 109 240 $48,000 $14,386 30.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 56 75 $20,250 $6,606 32.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 85 93 $11,625 $3,194 27.5%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 26 26 $2,080 $538.66 25.9%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 94 198 $53,460 $13,572 25.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 135 224 $44,800 $9,848 22.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 60 65 $8,125 $1,881 23.2%

About Dana Delaski, NP-C

Dana Delaski, NP-C is a Family healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2010. The National Provider Identifier (NPI) number assigned to this provider is 1467753772.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dana Delaski, NP-C has received a total of $145,155 in payments from pharmaceutical and medical device companies, with $12,552 received in 2024. These payments were reported across 679 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($84,118).

As a Medicare-enrolled provider, Delaski has provided services to 986 Medicare beneficiaries, totaling 1,614 services with total Medicare billing of $91,010. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Jackson, MS
  • Active Since 11/03/2010
  • Last Updated 04/10/2014
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1467753772

Products in Payments

  • JAKAFI (Drug) $68,665
  • MONJUVI (Drug) $67,377
  • BRUKINSA (Drug) $458.20
  • SARCLISA (Biological) $368.92
  • REBLOZYL (Biological) $350.65
  • IMBRUVICA (Drug) $281.93
  • VENCLEXTA (Biological) $244.58
  • SOMATULINE DEPOT (Drug) $230.69
  • MONOFERRIC (Drug) $228.03
  • CALQUENCE (Drug) $214.56
  • ICLUSIG (Drug) $207.28
  • KEYTRUDA (Biological) $190.47
  • Endari (Drug) $177.22
  • ADCETRIS (Biological) $157.69
  • Pomalyst (Drug) $148.54
  • Venclexta (Biological) $142.64
  • Yescarta (Drug) $131.64
  • AYVAKIT (Drug) $128.07
  • EPKINLY (Drug) $125.82
  • ONUREG (Drug) $125.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Jackson